Cargando…

The combined role of PET/CT metabolic parameters and inflammatory markers in detecting extensive disease in small cell lung cancer

The combined role of inflammatory markers [including neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/lymphocyte ratio (MLR), and systemic immune-inflammation index (SII)] and PET/CT metabolic parameters [including maximum standardized uptake value (SUVmax), mean standard...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yao, Sun, Jin, Li, Danming, Li, Yangyang, Li, Tiannv, Hu, Yuxiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515531/ https://www.ncbi.nlm.nih.gov/pubmed/36185188 http://dx.doi.org/10.3389/fonc.2022.960536

Ejemplares similares

The Role of the Metabolic Parameters of (18)F-FDG PET/CT in Patients With Locally Advanced Cervical Cancer
por: Wang, Dunhuang, et al.
Publicado: (2021)

A preliminary investigation of the relationship between (18)F-FDG PET/CT metabolic parameters and prognosis in angioimmunoblastic T-cell lymphoma
por: Hu, Lanping, et al.
Publicado: (2023)

Investigating (18)F-FDG PET/CT Parameters as Prognostic Markers for Differentiated Thyroid Cancer: A Systematic Review
por: Wang, Hongxi, et al.
Publicado: (2021)

The value of combined PET/MRI, CT and clinical metabolic parameters in differentiating lung adenocarcinoma from squamous cell carcinoma
por: Tang, Xin, et al.
Publicado: (2022)

Role of (18)FDG PET/CT metabolic parameters in predicting hematological toxicity during chemoradiotherapy for locally advanced cervical cancer
por: Meng, Tianyu, et al.
Publicado: (2022)

Prediction value of (18)F-FDG PET/CT intratumor metabolic heterogeneity parameters for recurrence after radical surgery of stage II/III colorectal cancer
por: Liu, Xin, et al.
Publicado: (2022)

The predictive value of total-body PET/CT in non-small cell lung cancer for the PD-L1 high expression
por: Hu, Bingxin, et al.
Publicado: (2022)

Prognostic value of baseline total metabolic tumour volume of (18)F-FDG PET/CT imaging in patients with angioimmunoblastic T-cell lymphoma
por: Gong, Huanyu, et al.
Publicado: (2021)

(18)F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment
por: Liu, Jie, et al.
Publicado: (2021)

Prognostic prediction by (18)F-FDG-PET/CT parameters in patients with neuroblastoma: a systematic review and meta-analysis
por: Hu, Ruimin, et al.
Publicado: (2023)

Prognostic Significance of Regional/Systemic Metabolic Parameters on (18)F-FDG PET in Pulmonary Lymphoepithelioma-Like Carcinoma
por: Li, Yongjiang, et al.
Publicado: (2021)

Additional Value of PET/CT-Based Radiomics to Metabolic Parameters in Diagnosing Lynch Syndrome and Predicting PD1 Expression in Endometrial Carcinoma
por: Wang, Xinghao, et al.
Publicado: (2021)

Preoperative PET/CT score can predict incomplete resection after debulking surgery for advanced serous ovarian cancer better than CT score, MTV, tumor markers and hematological markers
por: Wang, Jie, et al.
Publicado: (2022)

The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma
por: Gong, Huanyu, et al.
Publicado: (2022)

(18)F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer
por: Dong, Siying, et al.
Publicado: (2022)

Value of (11)C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases
por: Zhou, Shuoming, et al.
Publicado: (2021)

Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by (18)F-FDG PET/CT Radiomics and Clinicopathological Characteristics
por: Li, Jihui, et al.
Publicado: (2021)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

Recent and current advances in PET/CT imaging in the field of predicting epidermal growth factor receptor mutations in non-small cell lung cancer
por: Hu, Na, et al.
Publicado: (2022)

Prognostic value of pretreatment (18)F-FDG PET/CT metabolic parameters in esophageal high-grade neuroendocrine carcinoma: A bicenter retrospective study
por: Hou, Guozhu, et al.
Publicado: (2023)

Prediction of extracapsular extension in prostate cancer using the Likert scale combined with clinical and pathological parameters
por: Wang, Jun-guang, et al.
Publicado: (2023)

The role of PET/CT in radiotherapy for nasopharyngeal carcinoma
por: Li, Hongjia, et al.
Publicado: (2022)

Locoregional Extension Patterns of Nasopharyngeal Carcinoma Detected by FDG PET/MR
por: Cao, Caineng, et al.
Publicado: (2021)

Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR
por: Zhang, Zaizhu, et al.
Publicado: (2022)

Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer
por: Ming, Yue, et al.
Publicado: (2020)

Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET/CT
por: Li, Hongyan, et al.
Publicado: (2022)

A machine learning-based PET/CT model for automatic diagnosis of early-stage lung cancer
por: Wang, Huoqiang, et al.
Publicado: (2023)

Frontiers and hotspots of (18)F-FDG PET/CT radiomics: A bibliometric analysis of the published literature
por: Liu, Xinghai, et al.
Publicado: (2022)

The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges
por: Hu, Qiuyuan, et al.
Publicado: (2023)

Prognostic value of (18)F-FDG PET/CT radiomic model based on primary tumor in patients with non-small cell lung cancer: A large single-center cohort study
por: Li, Jihui, et al.
Publicado: (2022)

4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CT
por: Chi, Alexander, et al.
Publicado: (2014)

Habitat Imaging-Based (18)F-FDG PET/CT Radiomics for the Preoperative Discrimination of Non-small Cell Lung Cancer and Benign Inflammatory Diseases
por: Chen, Ling, et al.
Publicado: (2021)

Predictive value of intratumoral-metabolic heterogeneity derived from (18)F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma
por: Zhang, Li, et al.
Publicado: (2023)

The role of PET/CT in cervical cancer
por: Herrera, Fernanda G., et al.
Publicado: (2013)

Reliability of gradient-based segmentation for measuring metabolic parameters influenced by uptake time on 18F-PSMA-1007 PET/CT for prostate cancer
por: Lau, Yu Ching, et al.
Publicado: (2022)

Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis
por: Kwee, Thomas C., et al.
Publicado: (2008)

Case report and literature review: PET/CT in the evaluation of response to treatment of liver metastasis from colorectal cancer with DEBIRI-TACE
por: Jin, Lan, et al.
Publicado: (2023)

(18)F-FDG PET/CT radiomics for prediction of lymphovascular invasion in patients with early stage non-small cell lung cancer
por: Wang, Jie, et al.
Publicado: (2023)

Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases
por: Wang, Chunyu, et al.
Publicado: (2023)

Diagnostic Value of Delayed PET/MR in Liver Metastasis in Comparison With PET/CT
por: Zhou, Nina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3r5tej9gk8lsai44lgt89eeadm